The minister is responsible for the regulatory framework. That's why an new regulation came into force on July 1, 2022, to bring patented medicine prices in Canada in line with prices elsewhere in the world
The board, on the other hand, is an independent quasi-judicial body responsible for developing the guidelines needed to support the regulatory changes.